GLS and GOT2 as Prognostic Biomarkers Associated with Dendritic Cell and Immunotherapy Response in Breast Cancer

Researchers found that the key factors of glutamine metabolism, glutaminase 1 (GLS) and mitochondrial aspartate transaminase (GOT2), showed opposite expression patterns in breast cancer samples.